STATE OF WISCONSIN INVESTMENT BOARD
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 854157
MADISON, WI
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,789,566
-$1,016,440 QoQ
Shares Held
308,546
-13.7% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $146,075,839 across 40 Drug Manufacturers - Specialty & Generic names. XERS ranks #17 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
236,309 | $27,934,086 | |
| 2 | VTRS |
Viatris Inc
|
1,529,115 | $20,658,343 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
96,261 | $12,681,424 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
21,326 | $12,645,891 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
361,622 | $10,892,054 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
126,437 | $9,590,246 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
313,166 | $7,494,062 | |
| 8 | ALKS |
Alkermes plc.
|
139,333 | $4,926,814 |
All Filings in XERS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,789,566 | 308,546 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,806,006 | 357,453 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,853,306 | 350,529 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,298,353 | 278,020 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $111,309 | 20,275 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||